Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

KOD
Kodiak Sciences Inc Common Stock
stock NASDAQ

At Close
Jul 6, 2026 3:59:41 PM EDT
37.02USD-3.944%(-1.52)436,200
32.39Bid   37.46Ask   5.07Spread
Pre-market
Jul 6, 2026 9:01:30 AM EDT
39.00USD+1.194%(+0.46)7,173
After-hours
Jul 2, 2026 4:38:30 PM EDT
38.60USD+0.312%(+0.12)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
10:12AM EST  Citigroup Maintains Neutral on Kodiak Sciences, Lowers Price Target to $70   Benzinga
Jan 18, 2022
10:20AM EST  Morgan Stanley Maintains Equal-Weight on Kodiak Sciences, Raises Price Target to $122   Benzinga
Jan 11, 2022
10:38AM EST  52 Weeks High And Low Article   Benzinga
Jan 3, 2022
04:35PM EST  Companies To Participate In JP Morgan Healthcare Conference Jan. 11: Cytokinetics, iTeos, Ultragenyx, Cara Therapeutics, Kiniksa Pharma, Nurix Therapeutics, Neurocrine Biosciences, Berkeley Lights, Sema4, Repare Therapeutics, Terns Pharma, CONMED, Talkspace, Kodiak Sciences, Sotera Health, Eagle Pharma   Benzinga
04:12PM EST  Companies To Participate In JP Morgan Healthcare Conference Jan. 11: Cytokinetics, iTeos, Ultragenyx, Cara Therapeutics, Kiniksa Pharma, Nurix Therapeutics, Neurocrine Biosciences, Berkeley Lights, Sema4, Repare Therapeutics, Terns Pharma, CONMED, Talkspace, Kodiak Sciences   Benzinga
04:06PM EST  Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference   PR Newswire
Dec 16, 2021
05:50AM EST  Kodiak Sciences Completed Enrollment in BEACON Phase 3 Clinical Trial of KSI-301 in Patients with Retinal Vein Occlusion   Benzinga
05:34AM EST  Kodiak Sciences Completes Enrollment In BEACON Phase 3 Clinical Trial Of KSI-301 In Retinal Vein Occlusion   RTTNews
05:30AM EST  Kodiak Sciences Completes Enrollment in BEACON Phase 3 Clinical Trial of   PR Newswire
Nov 11, 2021
10:14AM EST  Citigroup Maintains Neutral on Kodiak Sciences, Raises Price Target to $114   Benzinga
Nov 9, 2021
06:00PM EST  Kodiak Sciences Q3 EPS $(1.30) Down From $(0.80) YoY   Benzinga
04:31PM EST  Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent   PR Newswire
Nov 8, 2021
04:06PM EST  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
Oct 2, 2021
03:07PM EDT  Last Week's Notable Insider Buys Included Evergy, Frontier Communications And More   Benzinga
Sep 18, 2021
12:14PM EDT  The Past Week's Notable Insider Buys: Continental Resources, Oscar Health And More   Benzinga
Sep 11, 2021
01:21PM EDT  The Past Week's Notable Insider Buys: Chipotle, Krispy Kreme, Petco Health And More   Benzinga
Sep 1, 2021
06:57AM EDT  Biopharmaceutical company Kodiak Sciences Inc. (KOD) announced Wednesday new seven-year performance stock option awards under a Long-Term Performance Incentive Plan (LTPIP) for named executive officers (NEOs) as well as other eligible Kodiak employees. This will be subject to stockholder approval of the LTPIP at a special meeting expected to be held in October.   RTTNews
05:53AM EDT  Kodiak Sciences Announces New Seven-year Performance Stock Option Awards   RTTNews
05:45AM EDT  Kodiak Sciences Announces New Long-Term Performance Incentive Plan   PR Newswire
Aug 31, 2021
05:02AM EDT  Kodiak Sciences to Present at the Morgan Stanley 19th Annual Global Healthcare   PR Newswire
Aug 21, 2021
02:07PM EDT  The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More   Benzinga
Aug 14, 2021
12:33PM EDT  The Past Week's Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More   Benzinga
Aug 9, 2021
04:36PM EDT  Kodiak Sciences Q2 EPS $(1.08) Down From $(0.58) YoY   Benzinga
04:03PM EDT  Kodiak Sciences Q2 Loss/share $1.08 Vs. Loss $0.58 Year Ago   RTTNews
04:02PM EDT  Kodiak Sciences Announces Second Quarter 2021 Financial Results and Recent   PR Newswire
Jul 23, 2021
07:33AM EDT  Kodiak Sciences Has Declined $125M Funding From Baker Bros Citing Strong Balance Sheet   Benzinga
06:17AM EDT  Kodiak Sciences Reported in 8-K Filing that Baker Bros Acknowledged in a Letter that Second Funding Amount Would Not Paid; Royalty Amount on Sales of KSI-301 Would be Reduced from $1.025B to $450M   Benzinga
May 20, 2021
07:01PM EDT  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
May 19, 2021
09:58AM EDT  The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Kodiak Sciences Inc. (Kodiak) (NASDAQ: KOD).   GlobeNewswire Inc
May 11, 2021
10:33AM EDT  Barclays Maintains Underweight on Kodiak Sciences, Lowers Price Target to $86   Benzinga
10:32AM EDT  BMO Capital Maintains Market Perform on Kodiak Sciences, Lowers Price Target to $104   Benzinga
10:21AM EDT  Roth Capital Upgrades Kodiak Sciences to Buy, Lowers Price Target to $149   Benzinga
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
05:48PM EDT  Kodiak Sciences Filing Shows Registration For ~14M Share Common Stock Offering Via Selling Shareholders   Benzinga
11:10AM EDT  Shares of Kodiak Sciences Inc. (KOD) are currently losing nearly 15% on Monday morning after reporting its first-quarter results.   RTTNews
05:31AM EDT  Kodiak Sciences Announces First Quarter 2021 Financial Results and Recent   PR Newswire
May 4, 2021
09:07AM EDT  Truist Securities Maintains Buy on Kodiak Sciences, Raises Price Target to $147   Benzinga
Apr 21, 2021
07:00PM EDT  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
Apr 19, 2021
10:44AM EDT  Morgan Stanley Maintains Equal-Weight on Kodiak Sciences, Lowers Price Target to $119   Benzinga
Mar 12, 2021
06:16AM EST  Evercore ISI Group Initiates Coverage On Kodiak Sciences with Outperform Rating   Benzinga
Mar 8, 2021
10:59AM EST  Morgan Stanley Maintains Equal-Weight on Kodiak Sciences, Raises Price Target to $133   Benzinga
Mar 2, 2021
04:12PM EST  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
Mar 1, 2021
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021   Benzinga
08:01AM EST  Barclays Downgrades Kodiak Sciences to Underweight, Raises Price Target to $90   Benzinga
05:32AM EST  Kodiak Sciences Q4 Net Loss $46.6 Mln Or $0.97/Shr Vs Loss Of $15.6 Mln Or $0.40/Shr Last Year   RTTNews
05:30AM EST  Kodiak Sciences Announces Fourth Quarter and Full Year 2020 Financial Results   PR Newswire
Feb 17, 2021
10:12AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021   Benzinga
08:36AM EST  10 Biggest Price Target Changes For Wednesday   Benzinga
08:28AM EST  Roth Capital Downgrades Kodiak Sciences to Neutral, Raises Price Target to $155   Benzinga
Feb 16, 2021
06:07AM EST  Kodiak Sciences' KSI-301 Shows Durable Benefit In Retinal Disease Settings   Benzinga
Feb 13, 2021
08:28AM EST  Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the Angiogenesis, Exudation and Degeneration 2021 Annual Meeting   PR Newswire
Feb 6, 2021
12:42PM EST  The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight   Benzinga
Feb 2, 2021
07:15AM EST  Kodiak Sciences Highlights Presentation Of KSI-301 Phase 1b Trial Study Data At Angiogenesis, Exudation, Degeneration On Feb. 13, 2021 At 8:30 a.m. EST   Benzinga
07:14AM EST  Study Data at Angiogenesis, Exudation, and Degeneration 2021 - Virtual Edition   PR Newswire
Jan 25, 2021
12:40PM EST  Why Kodiak Sciences Stock Is Trading Lower Today   Benzinga
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2021   Benzinga
08:14AM EST  BMO Capital Downgrades Kodiak Sciences to Market Perform, Raises Price Target to $148   Benzinga
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
Jan 5, 2021
08:03AM EST  Kodiak Sciences to Present at the J.P. Morgan Healthcare Conference   PR Newswire
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 17, 2020
10:17AM EST  Benzinga's Top Upgrades, Downgrades For December 17, 2020   Benzinga
09:54AM EST  Berenberg Initiates Coverage On Kodiak Sciences with Buy Rating, Announces Price Target of $156   Benzinga
Dec 11, 2020
10:25AM EST  Benzinga's Top Upgrades, Downgrades For December 11, 2020   Benzinga
06:17AM EST  Citigroup Initiates Coverage On Kodiak Sciences with Neutral Rating, Announces Price Target of $134   Benzinga
Nov 30, 2020
10:01AM EST  Benzinga's Top Upgrades, Downgrades For November 30, 2020   Benzinga
06:16AM EST  JP Morgan Downgrades Kodiak Sciences to Neutral, Announces $125 Price Target   Benzinga
Nov 20, 2020
04:03PM EST  Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares   PR Newswire
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
01:19PM EST  Yahoo Finance Trending Stocks For Wednesday, Nov. 18, 2020: NKLA, BA, TGT, LOW, PFE, NIO, NAKD, SPCE, RIOT, QCOM, CIIC, KOD, BYND, RIDE, GM, DNK, SCKT, F, JMIA, ROOT, TJX, PCG, IDEX, BABA, MFGP, RIG, XXII, KZIA   Benzinga
12:09PM EST  Mid-Day Market Update: PaySign Falls After Q3 Earnings; VAALCO Energy Shares Jump   Benzinga
10:15AM EST  Kodiak Sciences Inc. (KOD) shares are gaining more than 22 percent on Wednesday morning trade. The biopharmaceutical company announced the pricing of an underwritten public offering of 5,193,237 shares of its common stock at a price to the public of $108.00 per share.   RTTNews
Nov 17, 2020
09:21PM EST  Kodiak Sciences Prices Underwritten Public Offering Of 5.19 Mln Shares At $108.00/shr   RTTNews
09:03PM EST  Kodiak Sciences Announces Pricing of $560.9 Million Public Offering of Common   PR Newswire
Nov 16, 2020
04:02PM EST  Kodiak Sciences Announces Proposed Offering Of Common Stock   RTTNews
04:02PM EST  Kodiak Sciences Reports $400M Common Stock Offering   Benzinga
04:01PM EST  Kodiak Sciences Announces Proposed Offering of Common Stock   PR Newswire
07:15AM EST  Kodiak Sciences Completes Enrollment Of DAZZLE Phase 2b/3 Pivotal Study Of KSI-301   RTTNews
06:55AM EST  Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration   Benzinga
06:53AM EST  Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of   PR Newswire
06:40AM EST  Morgan Stanley Downgrades Kodiak Sciences to Equal-Weight, Announces $125 Price Target   Benzinga
Nov 13, 2020
09:45AM EST  Benzinga's Top Upgrades, Downgrades For November 13, 2020   Benzinga
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
06:21AM EST  Goldman Sachs Downgrades Kodiak Sciences to Neutral, Announces $105 Price Target   Benzinga
Nov 12, 2020
04:12PM EST  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
05:17AM EST  Kodiak Sciences Announced Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology 2020 Virtual Meeting   Benzinga
Nov 11, 2020
11:34PM EST  Kodiak Sciences Presents KSI-301 Phase 1b Clinical Study Data Focused On Diabetic Macular Edema At AAO   RTTNews
11:28PM EST  Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting   PR Newswire
Nov 10, 2020
11:06AM EST  Roth Capital Maintains Buy on Kodiak Sciences, Raises Price Target to $133   Benzinga
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
05:41AM EST  Kodiak Sciences Q3 Net Loss $36.1 Mln Or $0.80/Shr Vs Loss Of $12.4 Mln Or $0.33/Shr Last Year   RTTNews
05:34AM EST  Kodiak Science Q3 EPS $(0.80) Misses $(0.67) Estimate   Benzinga
05:30AM EST  Kodiak Sciences Announces Third Quarter 2020 Financial Results and Recent   PR Newswire
Nov 6, 2020
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Oct 29, 2020
09:14AM EDT  AbCellera And Kodiak Sciences Enter Second Antibody Discovery Collaboration For Ophthalmology Targets   Benzinga
Oct 27, 2020
09:01AM EDT  Stocks Trading Near 52-Week Highs Before Open On Tuesday, Oct. 27, 2020: XLNX, CROX, KOD, VRNS, EXAS, CMI, TPB   Benzinga
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Oct 23, 2020
10:25AM EDT  Kodiak Sciences Option Alert: Dec 18 $110 Calls Sweep (2) near the Ask: 500 @ $4.5 vs 0 OI; Earnings 11/10 Before Open [est] Ref=$91.745   Benzinga
Oct 5, 2020
09:07AM EDT  Kodiak Sciences Treats First Patients In Three Phase 3 Studies Of KSI-301   Benzinga
09:03AM EDT  Studies in Diabetic Macular Edema and One Study in Macular Edema Due to Retinal Vein Occlusion   PR Newswire
Sep 27, 2020
06:12PM EDT  Notable Insider Buys Last Week: Snowflake, Broadcom And More   Benzinga
Sep 13, 2020
11:06AM EDT  Notable Insider Buys Last Week: Keurig Dr Pepper, Xerox And More   Benzinga
Sep 2, 2020
04:08PM EDT  Kodiak Sciences to Present at Upcoming Conferences   PR Newswire
Aug 22, 2020
04:53PM EDT  Notable Insider Buys Last Week: Avis Budget, Xerox And Many More   Benzinga
Aug 20, 2020
04:08PM EDT  Kodiak Sciences And Kodiak Sciences GmbH On August 14 Entered Into A Bioconjugation Addendum With Lonza For Manufacturing Of Clinical And Commercial Supply Of Drug Substance For KSI-301   Benzinga
Aug 10, 2020
05:56AM EDT  Kodiak Sciences Q2 Net Loss $26.0 Mln Or $0.58/Shr Vs Loss Of $11.4 Mln Or $0.31/Shr Last Year   RTTNews
05:30AM EDT  Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent   PR Newswire
Jul 28, 2020
08:38AM EDT  SunTrust Robinson Humphrey Maintains Buy on Kodiak Sciences, Lowers Price Target to $89   Benzinga
Jul 16, 2020
04:40PM EDT  Kodiak Sciences To Host R&D Webcast To Review Recent Data From Ongoing Phase 1b Study Of KSI-301 And Highlight KSI-301 Clinical Development Progress   Benzinga
04:39PM EDT  Phase 1b Study of KSI-301 and Highlight KSI-301 Clinical Development Progress   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC